Brian F. Chapin

4.2k total citations
116 papers, 1.9k citations indexed

About

Brian F. Chapin is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Brian F. Chapin has authored 116 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 102 papers in Pulmonary and Respiratory Medicine, 24 papers in Cancer Research and 22 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Brian F. Chapin's work include Prostate Cancer Treatment and Research (75 papers), Prostate Cancer Diagnosis and Treatment (72 papers) and Cancer, Lipids, and Metabolism (18 papers). Brian F. Chapin is often cited by papers focused on Prostate Cancer Treatment and Research (75 papers), Prostate Cancer Diagnosis and Treatment (72 papers) and Cancer, Lipids, and Metabolism (18 papers). Brian F. Chapin collaborates with scholars based in United States, Canada and United Kingdom. Brian F. Chapin's co-authors include Scott E. Delacroix, John W. Davis, Christopher G. Wood, Roger Chou, Todd M. Morgan, Stephen H. Culp, William Oh, Adam S. Kibel, Rodney H. Breau and Alicia K. Morgans and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer.

In The Last Decade

Brian F. Chapin

111 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Brian F. Chapin United States	22	1.5k	406	349	345	304	116	1.9k
Vito Cucchiara Italy	27	1.3k 0.8×	248 0.6×	238 0.7×	268 0.8×	267 0.9×	69	1.9k
Paul C.M.S. Verhagen Netherlands	19	1.6k 1.0×	196 0.5×	289 0.8×	267 0.8×	371 1.2×	49	1.9k
Wolfgang Loidl Austria	23	1.5k 1.0×	448 1.1×	247 0.7×	140 0.4×	768 2.5×	71	1.9k
Michaël Peyromaure France	25	1.3k 0.9×	413 1.0×	172 0.5×	344 1.0×	252 0.8×	126	2.3k
Robert Given United States	19	1.7k 1.1×	432 1.1×	474 1.4×	262 0.8×	555 1.8×	57	2.2k
Guillaume Ploussard France	34	2.5k 1.6×	503 1.2×	355 1.0×	381 1.1×	329 1.1×	112	3.2k
Raymond S. Lance United States	24	1.4k 0.9×	647 1.6×	509 1.5×	864 2.5×	192 0.6×	51	2.6k
Amit Bahl United Kingdom	24	954 0.6×	932 2.3×	578 1.7×	437 1.3×	300 1.0×	181	2.4k
Oleksandr N. Kryvenko United States	25	1.6k 1.0×	497 1.2×	335 1.0×	536 1.6×	270 0.9×	119	2.4k
J Bellmunt Spain	14	967 0.6×	751 1.8×	434 1.2×	330 1.0×	111 0.4×	31	1.9k

Countries citing papers authored by Brian F. Chapin

Since Specialization

Citations

This map shows the geographic impact of Brian F. Chapin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian F. Chapin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian F. Chapin more than expected).

Fields of papers citing papers by Brian F. Chapin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brian F. Chapin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian F. Chapin. The network helps show where Brian F. Chapin may publish in the future.

Co-authorship network of co-authors of Brian F. Chapin

This figure shows the co-authorship network connecting the top 25 collaborators of Brian F. Chapin. A scholar is included among the top collaborators of Brian F. Chapin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brian F. Chapin. Brian F. Chapin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rais‐Bahrami, Soroush, et al.. (2025). Detection Rates of PSMA-PET Radiopharmaceuticals in Recurrent Prostate Cancer: A Systematic Review. Diagnostics. 15(10). 1224–1224.

Hassanzadeh, Comron, Osama Mohamad, Teresa L. Bruno, et al.. (2025). Early outcomes following local salvage treatment with MRI-assisted low-dose rate brachytherapy (MARS) for MRI-visible postsurgical bed recurrences and focal intraprostatic recurrences. Brachytherapy. 24(2). 231–237. 1 indexed citations

Morgan, Todd M., Stephen A. Boorjian, Mark K. Buyyounouski, et al.. (2024). Salvage Therapy for Prostate Cancer: AUA/ASTRO/SUO Guideline Part III: Salvage Therapy After Radiotherapy or Focal Therapy, Pelvic Nodal Recurrence and Oligometastasis, and Future Directions. The Journal of Urology. 211(4). 526–532. 13 indexed citations

Fang, Andrew M., Justin R. Gregg, Curtis A. Pettaway, et al.. (2024). Whole‐body MRI for staging prostate cancer: a narrative review. British Journal of Urology. 135(1). 13–21. 2 indexed citations

Lowentritt, Benjamin, Ashesh B. Jani, Brian T. Helfand, et al.. (2024). Impact of Clinical Factors on 18F-Flotufolastat Detection Rates in Men With Recurrent Prostate Cancer: Exploratory Analysis of the Phase 3 SPOTLIGHT Study. Advances in Radiation Oncology. 9(8). 101532–101532. 4 indexed citations

Morgan, Todd M., Stephen A. Boorjian, Mark K. Buyyounouski, et al.. (2024). Salvage Therapy for Prostate Cancer: AUA/ASTRO/SUO Guideline Part II: Treatment Delivery for Non-metastatic Biochemical Recurrence After Primary Radical Prostatectomy. The Journal of Urology. 211(4). 518–525. 9 indexed citations

Michalski, Jeff M., et al.. (2023). Detection Rate of 18F-rhPSMA-7.3 PET in Patients with Suspected Prostate Cancer Recurrence at PSA Levels <1 ng/mL: Data from the Phase 3 SPOTLIGHT Study. International Journal of Radiation Oncology*Biology*Physics. 117(2). S35–S36. 1 indexed citations

Bathala, Tharakeswara, Steven J. Frank, Quynh‐Nhu Nguyen, et al.. (2023). Definitive local therapy for T4 prostate cancer associated with improved local control and survival. British Journal of Urology. 132(3). 307–313. 2 indexed citations

Ranasinghe, Weranja, Daniel D. Shapiro, Miao Zhang, et al.. (2021). Optimizing the diagnosis and management of ductal prostate cancer. Nature Reviews Urology. 18(6). 337–358. 22 indexed citations

10.

Wilkins, Lamont, Jeffrey J. Tosoian, Chad A. Reichard, et al.. (2021). Oncologic outcomes among Black and White men with grade group 4 or 5 (Gleason score 8‐10) prostate cancer treated primarily by radical prostatectomy. Cancer. 127(9). 1425–1431. 8 indexed citations

11.

Davis, John W., Amado J. Zurita, Xuemei Wang, et al.. (2021). Abiraterone acetate plus prednisone in non-metastatic biochemically recurrent castration-naïve prostate cancer. European Journal of Cancer. 157. 259–267. 12 indexed citations

12.

Chapin, Brian F., et al.. (2021). Therapeutic Consequences of Omitting a Pelvic Lymph Node Dissection at Radical Prostatectomy when Grade and/or Stage Increase. Urology. 155. 144–151. 1 indexed citations

13.

Subudhi, Sumit K., Luis M. Vence, Hao Zhao, et al.. (2020). Neoantigen responses, immune correlates, and favorable outcomes after ipilimumab treatment of patients with prostate cancer. Science Translational Medicine. 12(537). 116 indexed citations

14.

Bathala, Tharakeswara, Brian F. Chapin, Chad Tang, et al.. (2020). Comparison of Diagnostic Utility of Fluciclovine PET/CT Versus Pelvic Multiparametric MRI for Prostate Cancer in the Pelvis in the Setting of Rising PSA After Initial Treatment. Clinical Nuclear Medicine. 45(5). 349–355. 6 indexed citations

15.

Ranasinghe, Weranja, Daniel D. Shapiro, Hyunsoo Hwang, et al.. (2020). Ductal Prostate Cancers Demonstrate Poor Outcomes with Conventional Therapies. European Urology. 79(2). 298–306. 29 indexed citations

16.

Hoffman, Richard M., Robert J. Volk, Brian F. Chapin, et al.. (2019). Impact of Multidisciplinary Counseling on Awareness of Prostate Cancer Treatment Options. International Journal of Radiation Oncology*Biology*Physics. 105(1). E442–E442. 1 indexed citations

17.

Babaian, Kara N., Mary Achim, Patricia Troncoso, et al.. (2018). Surgeon‐led prostate cancer lymph node staging: pathological outcomes stratified by robot‐assisted dissection templates and patient selection. British Journal of Urology. 122(1). 66–75. 11 indexed citations

18.

Williams, Stephen B., Jinhai Huo, Brian F. Chapin, Benjamin D. Smith, & Richard M. Hoffman. (2017). Impact of urologists’ ownership of radiation equipment in the treatment of prostate cancer. Prostate Cancer and Prostatic Diseases. 20(3). 300–304. 2 indexed citations

19.

Williams, Stephen B., John W. Davis, Xuemei Wang, et al.. (2015). Neoadjuvant Systemic Therapy Before Radical Prostatectomy in High-Risk Prostate Cancer Does Not Increase Surgical Morbidity: Contemporary Results Using the Clavien System. Clinical Genitourinary Cancer. 14(2). 130–138. 14 indexed citations

20.

Chapin, Brian F., Brian H. Eisner, & Shahin Tabatabaei. (2007). MP-01.26 (podium): Use of pulsed KTP laser coagulation of submucosal telangiectatic vessels in patients with radiation cystitis. Urology. 70(3). 46–46. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact